Great News

Exclusive: Ocugen plans to sell 100 million Indian vaccine doses in the US by 2021

Exclusive: Ocugen plans to sell 100 million Indian vaccine doses in the US by 2021

In a turnout for Kuroda, the BOJ may scramble your asset purchase goal

UPDATE 1-Australia c.bank emphasizes lower rate outlook for longer term

Three Norwegian people are being treated for “abnormal symptoms” after AstraZeneca COVID-19 shots

AstraZeneca’s lowest EU vaccine supply target depends on factory approval: document

Canadian judge rejects Huawei CFO’s attempt to use staff statements as evidence in U.S. enlargement case

U.S. stocks close mixed as Dow notes the fifth straight high record

US STOCKS-Dow notes the fifth straight high record

U.S. producer prices will rise sharply in February